News

Published on 20 Apr 2022 on Zacks via Yahoo Finance

SeaSpine (SPNE) Moves 5.8% Higher: Will This Strength Last?


Article preview image

SeaSpine Holdings SPNE shares rallied 5.8% in the last trading session to close at $10.92. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.4% loss over the past four weeks.

SeaSpine Holdings recorded a strong price increase on investors’ optimism surrounding the company’s upcoming first quarter 2022 results, which is set to release on May 3, after the closing bell. In the last-reported fourth quarter 2021, the company recorded loss of 52 cents per share, much wider than the Zacks Consensus Estimate of a loss of 36 cents per share. The company’s revenues of $55.6 million for the fourth quarter surpassed the Zacks Consensus Estimate by 1.3%. SeaSpine Holdings expects to report first quarter revenues in the band of $48.5-$49.5 million, reflecting growth of nearly 16%-18% year over year. The Zacks Consensus Estimates for the company’s earnings and revenues also suggest strong year over year growth.

This medical technology company is expected to post quarterly loss of $0.35 per share in its upcoming report, which represents a year-over-year change of +23.9%. Revenues are expected to be $48.92 million, up 16.6% from the year-ago quarter.

NASDAQ.MASI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Reasons Why You Should Retain Masimo (MASI) Stock for Now

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its researc...

Zacks via Yahoo Finance 19 Apr 2024

Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?

Masimo MASI is witnessing strong momentum, with its shares having rallied 17.9% year to date comp...

Zacks via Yahoo Finance 17 Apr 2024

Stifel upgrades Masimo to buy, sees room for share price appreciation (NASDAQ:MASI)

Stifel upgraded Masimo (MASI) to buy, citing improvement in the company's healthcare business, gr...

Seeking Alpha 16 Apr 2024

Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?

Key Insights Masimo's estimated fair value is US$181 based on 2 Stage Free Cash Flow to EquityCur...

Simply Wall St. via Yahoo Finance 14 Apr 2024

Can Mixed Fundamentals Have A Negative Impact on Masimo Corporation (NASDAQ:MASI) Current Share...

Masimo (NASDAQ:MASI) has had a great run on the share market with its stock up by a significant 2...

Simply Wall St. via Yahoo Finance 28 Mar 2024

Company News for Mar 26, 2024

Shares of Masimo Corporation (MASI) jumped 3.3% after the company announced that it was planning ...

Zacks via Yahoo Finance 27 Mar 2024

Masimo (MASI) Plans Consumer Business Spin-Off to Drive Growth

Masimo MASI recently announced that it is planning to separate its consumer business and will foc...

Zacks via Yahoo Finance 27 Mar 2024

Wells Fargo upgrades Masimo to overweight, cites spinoff plan (NASDAQ:MASI)

Wells Fargo raised its rating on Masimo (MASI) to overweight, citing the company’s plans to eithe...

Seeking Alpha 26 Mar 2024

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday’s Pre-Market Session -...

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on M...

Benzinga 25 Mar 2024

Activist Polan plans second proxy fight at Masimo - WSJ

Activist investor Politan Capital Management, which already holds two seats on Masimo Corp.'s...

Seeking Alpha 25 Mar 2024